Anti-Bevacizumab Antibody (AY9) (recommended for ADA assay), Unconjugated

Produktübersicht

• Artikelname: Anti-Bevacizumab Antibody (AY9) (recommended for ADA assay), Unconjugated
• Artikelnummer: ABS-BEB-Y9-100UG
• Hersteller Artikelnummer: BEB-Y9-100ug
• Alternativnummer: ABS-BEB-Y9-100UG
• Hersteller: AcroBiosystems
• Kategorie: Antikörper
• Spezies Reaktivität: Mouse
• Konjugation: Unconjugated

Produktbeschreibung

A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementaritydetermining regions of a murine anti

Produkteigenschaften

• Puffer: Tris with Glycine, Arginine and NaCl, pH7.5
• Quelle: Anti-Bevacizumab Antibodies (recommended for ADA assay) antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Bevacizumab.
• Expression System: Hybridoma
• Reinheit: 95%
• Formulierung: Powder
• Target-Kategorie: Bevacizumab